1.
Availability, cost, and prescription patterns of antihypertensive medications in primary health care in China: a nationwide cross-sectional survey
by Su, Meng
The Lancet (British edition), 2017, Vol.390 (10112), p.2559-2568
2.
A public health approach to global management of hypertension
by Angell, Sonia Y, MD
The Lancet (British edition), 2015, Vol.385 (9970), p.825-827
3.
Cost-Effectiveness of a Physician-Pharmacist Collaboration Intervention to Improve Blood Pressure Control
by Polgreen, Linnea A
Hypertension (Dallas, Tex. 1979), 2015, Vol.66 (6), p.1145-1151
4.
Prevention of cardiovascular disease in high-risk individuals in low-income and middle-income countries: health effects and costs
by Lim, Stephen S, PhD
The Lancet (British edition), 2007, Vol.370 (9604), p.2054-2062
5.
Medication Adherence and Persistence as the Cornerstone of Effective Antihypertensive Therapy
by Burnier, Michel
American Journal of Hypertension, 2006, Vol.19 (11), p.1190-1196
6.
Generating evidence from computerized healthcare utilization databases
by Corrao, Giovanni
Hypertension (Dallas, Tex. 1979), 2015, Vol.65 (3), p.490-498
7.
Patterns of Outpatient Antihypertensive Medication Use During Pregnancy in a Medicaid Population
by Bateman, Brian T
Hypertension (Dallas, Tex. 1979), 2012, Vol.60 (4), p.913-920
8.
Home Blood Pressure Monitoring in the Diagnosis and Treatment of Hypertension: A Systematic Review
by Stergiou, George S
American journal of hypertension, 2011, Vol.24 (2), p.123-134
9.
Comparative Cost-Effectiveness of Conservative or Intensive Blood Pressure Treatment Guidelines in Adults Aged 35–74 Years: The Cardiovascular Disease Policy Model
by Moise, Nathalie
Hypertension (Dallas, Tex. 1979), 2016, Vol.68 (1), p.88-96
10.
Physician–Pharmacist Collaborative Management: Narrowing the Socioeconomic Blood Pressure Gap
by Anderegg, Maxwell D
Hypertension (Dallas, Tex. 1979), 2016, Vol.68 (5), p.1314-1320
11.
Adherence and persistence of single-pill ARB/CCB combination therapy compared to multiple-pill ARB/CCB regimens
by Zeng, F
Current medical research and opinion, 2010, Vol.26 (12), p.2877-2887
12.
Self-measurement of blood pressure at home reduces the need for antihypertensive drugs: a randomized, controlled trial
by Verberk, Willem J
Hypertension (Dallas, Tex. 1979), 2007, Vol.50 (6), p.1019-1025
13.
Inhaled epoprostenol vs inhaled nitric oxide for refractory hypoxemia in critically ill patients
by Torbic, Heather, PharmD, BCPS
Journal of critical care, 2013, Vol.28 (5), p.844-848
14.
Cost analysis of medications in ophthalmology consultations using Mobile applications
by Young, Benjamin K
Graefe's archive for clinical and experimental ophthalmology, 2019, Vol.257 (8), p.1809-1810
15.
Left Ventricular Hypertrophy and Clinical Outcomes in Hypertensive Patients
by Ruilope, Luis M.
American journal of hypertension, 2008, Vol.21 (5), p.500-508
16.
The Cost Implications of Less Tight Versus Tight Control of Hypertension in Pregnancy (CHIPS Trial)
by Ahmed, Rashid J
Hypertension (Dallas, Tex. 1979), 2016, Vol.68 (4), p.1049-1055
17.
Dynamic View on Affordability of Fixed-Dose Combination Antihypertensive Drug Therapy
by Hong, Song Hee
American journal of hypertension, 2013, Vol.26 (7), p.879-887
18.
Variation in Number of Doses, Bottle Volume, and Calculated Yearly Cost of Generic and Branded Latanoprost for Glaucoma
by Queen, Joanna H
American journal of ophthalmology, 2016, Vol.163, p.70-74.e1
19.
High B-Type Natriuretic Peptide Hypertensives at Target Blood Pressure: Potential Role of β-Blockers to Reduce Their Elevated Risk
by Struthers, Allan D
Hypertension (Dallas, Tex. 1979), 2015, Vol.66 (5), p.927-932
20.
Nebivolol: A third-generation β-blocker for hypertension
by Cheng, Judy W.M., BS, PharmD, MPH, FCCP, BCPS
Clinical therapeutics, 2009, Vol.31 (3), p.447-462
